Resiliency Among Older Adults Receiving Lung Cancer Treatment
ROAR-LCT
3 other identifiers
interventional
18
1 country
1
Brief Summary
This trial studies how well physical therapy and progressive muscle relaxation works in improving physical performance and mood in older patients with stage IIIA-B or IV lung cancer who are undergoing treatment. Improving physical performance and mood may help older patients maintain an independent lifestyle by helping to improve their resilience, the ability to bounce back to normal functioning after a stressor or intervening health event such as treatment or disease progression. Giving physical therapy and progressive muscle relaxation may work in improving symptoms and quality of life in patients with lung cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2019
CompletedFirst Posted
Study publicly available on registry
January 18, 2020
CompletedStudy Start
First participant enrolled
January 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 22, 2022
CompletedResults Posted
Study results publicly available
November 15, 2023
CompletedNovember 15, 2023
October 1, 2023
1.4 years
November 26, 2019
June 5, 2023
October 24, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Recruitment Rates
Recruitment rates will be defined as the proportion of screened older adults accrued relative to those approached in the Ohio State University Comprehensive Cancer Center (OSUCCC) Thoracic Oncology Clinic. Successful recruitment rates will be defined as \>= 50% of older adults (\>= 60 years) approached agree to participate.
Up to 24 weeks
Adherence Rate
Study adherence will be defined as the completion of \>= 70% of the program sessions, repeated assessments, and collection of bio specimens either at the end of the study period or death, whichever occurs first.
Up to 24 weeks
Retention Rates
Retention rates will be defined as the percentage of participants not lost to follow-up.
Up to 24 weeks
Secondary Outcomes (2)
Functional Trajectories
At 12 months
Factors Associated With Resiliency
Up to 12 months
Study Arms (1)
Supportive Care (physical therapy, muscle relaxation)
EXPERIMENTALPatients participate physical therapy sessions consisting of cardiovascular and resistance training exercises in person or online and also undergo progressive muscle relaxation sessions once weekly for up to 12 weeks.
Interventions
Undergo physical therapy
Ancillary studies
Ancillary studies
Undergo progressive muscle relaxation
Eligibility Criteria
You may qualify if:
- Diagnosed with advanced lung cancer: unresectable stage IIIA, IIIB, or stage IV non-small cell lung cancer (NSCLC) or extensive stage small cell lung cancer (SCLC).
- Intent to receive treatment from the Ohio State University Comprehensive Cancer Center (OSUCCC) Thoracic Oncology Clinic.
- Willingness to participate and adhere to the study intervention program.
- Ability to understand and willingness to sign an informed consent document (or indicate approval or disapproval by another means).
You may not qualify if:
- Prisoners are excluded from participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Study opened in February of 2020 and COVID-19 lockdown in Ohio occurred in March of 2020. We had participants already in this first month of accrual who did decide to dropout due to COVID-19 related concerns. The study design was modified as most patients were being seen via virtual health for standard oncology care visits. The first and final intervention sessions were in-person with the remainder conducted via virtual health.
Results Point of Contact
- Title
- Dr. Carolyn Presley
- Organization
- The Ohio State University Comprehensive Cancer Center
Study Officials
- PRINCIPAL INVESTIGATOR
Carolyn J Presley, MD, MHS
Ohio State University Comprehensive Cancer Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 26, 2019
First Posted
January 18, 2020
Study Start
January 22, 2020
Primary Completion
June 22, 2021
Study Completion
June 22, 2022
Last Updated
November 15, 2023
Results First Posted
November 15, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share